SCHEMBL1709608

SCHEMBL1709608

O=C(Nc1ccc(Br)cn1)C(Sc1ccc(F)cc1)c1ccc(Cl)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR2 O15552 1/20 0.52
RAB9A P51151 7/20 0.49
NPC1 O15118 6/20 0.49
KMT2A Q03164 7/20 0.47
MEN1 O00255 6/20 0.47
SMN1; SMN2 Q16637 3/20 0.44
LMNA P02545 3/20 0.44
POLB P06746 2/20 0.42
BRD4 O60885 1/20 0.40
SORT1 Q99523 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
NPSR1 Q6W5P4 2/20 0.39
MITF O75030 1/20 0.39
TSHR P16473 3/20 0.39
ALDH1A1 P00352 2/20 0.39
PKM P14618 1/20 0.39
S1PR1 P21453 1/20 0.39
S1PR3 Q99500 1/20 0.39
KDM4E B2RXH2 1/20 0.38
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL934058 0.99 FFAR2 (0.51) FFAR2RAB9ANPC1KMT2AMEN1
SCHEMBL1709525 0.94 NPC1 (0.54) FFAR2RAB9ANPC1KMT2AMEN1
Hydrochloric Acid SCHEMBL933719 0.93 NPC1 (0.53) FFAR2RAB9ANPC1KMT2AMEN1
SCHEMBL935450 0.91 FFAR2 (0.56) FFAR2RAB9ANPC1KMT2AMEN1
SCHEMBL1709614 0.91 FFAR2 (0.56) FFAR2RAB9ANPC1KMT2AMEN1
Hydrochloric Acid SCHEMBL933845 0.90 FFAR2 (0.55) FFAR2RAB9ANPC1KMT2AMEN1
SCHEMBL933381 0.89 RAB9A (0.49) FFAR2RAB9ANPC1KMT2AMEN1
Hydrochloric Acid SCHEMBL933408 0.88 RAB9A (0.48) FFAR2RAB9ANPC1KMT2AMEN1
SCHEMBL1709527 0.86 NPC1 (0.52) FFAR2RAB9ANPC1KMT2AMEN1
Hydrochloric Acid SCHEMBL934425 0.85 NPC1 (0.51) FFAR2RAB9ANPC1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120088800-A1 2-(SUBSTITUTED) (ARYLMETHYL, ARYLOXY and ARYLTHIO))-N-(SUBSTITUTED PYRIDIN-2-YL)-2-(SUBSTITUTED ARYL) COMPOUNDS AS SUBTYPE-SELECTIVE MODULATORS OF SPHINGOSINE-1-PHOSPHATE-3 (S1P3) RECEPTORS ALLERGAN, INC. (US) 2012-04-12 US disclosed
WO-2011008475-A1 OPTIONALLY SUBSTITUTED 2-(ARYLMETHYL, ARYLOXY OR ARYLTHIO) -N- PYRIDIN-2 -YL-ARYL ACETAMIDE OR 2, 2-BIS (ARYL) -N-PYRIDIN-2-YL ACETAMIDE COMPOUNDS AS MEDICAMENTS FOR THE TREATMENT OF EYE DISEASES ALLERGAN, INC. (US) 2011-01-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088800-A1 2-(SUBSTITUTED) (ARYLMETHYL, ARYLOXY and ARYLTHIO))-N-(SUBSTITUTED PYRIDIN-2-YL)-2-(SUBSTITUTED ARYL) COMPOUNDS AS SUBTYPE-SELECTIVE MODULATORS OF SPHINGOSINE-1-PHOSPHATE-3 (S1P3) RECEPTORS S1PR3, S1PR5, S1PR1 FFAR2 117/4885RAB9A 2924/4885NPC1 1507/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.